Ganoderma lucidum on metabolic control in type 2 diabetes subjects - A double blinded placebo control study

Journal of Internal Medicine of Taiwan

Volumn 19, Issue 1, 2008, Pages 54-60

  Wang, Chen Wen ^a   Tschen, Johannes Scheng Ming ^a   Sheu, Wayne Huey Herng ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GANODERMA LUCIDUM EXTRACT; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PLACEBO; SULFONYLUREA;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; GANODERMA LUCIDUM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; TEST MEAL;

EID: 41149129698     PISSN: 10167390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jervell J. Type II Diabetes (NIDDM) can be prevented. IDF Bulletin 1997; 42: 1-3.
2. Tseng CH, Tseng CP, Chong CK, et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006; 49: 1755-60.
3. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Dellbanco TL. Unconventional medicine in the United States. N Engl J Med 1993; 328: 246-52.
4. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC. Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 1998; 15: 297-303.
5. Garrow D, Egede LE. National patterns and correlates of complementary and alternative medicine use in adults with diabetes. J Altern Complement Med 2006; 12: 895-902.
6. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med 2006; 12: 16-22.
7. Min BS, Gao JJ, Nakamura N, and Hattori M. Triperpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells. Chem Pharm Bull 2000; 48: 1026-33.
8. Shiao MS. Natural products of the medical fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chemical Record 2003; 3: 172-80.
9. Zhabg HN, He JH, Yuan L, Lin ZB. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage Life Sci 2003; 73: 2307-19.
10. Kadish AH, Litle RC, Stemberg JC. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968; 14: 116-31.
11. Hikino H, Ishiyama M, Suzuki Y, and Konno C. Mechanisms of hypoglycemic activity of ganoderan B: glycan of Ganoderma lucidum fruit bodies. Planta Med 1989; 55: 423-8.
12. Hikino H, Konno, C, Mirin Y, Hayashi T. Isolation and hypoglycemic activity of Ganoderans A and B, Glycans of Ganoderma lucidum fruit bodies1. Planta Med 1985; 51: 339-40.
13. Kino K, Mizumoto K, Sone T, et al. An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice. Diabetologia 1990; 33: 713-8.
14. Zhang HN, Lin ZB. Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol Sin 2004; 25: 191-5.
15. Kimura Y, Okuda H, Arichi S. Effects of the extracts of Ganoderma lucidum on blood glucose level in rats. Planta Med 1988; 54: 290-4.
16. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(Ic). Diabetes Care 2003; 26: 881-5.
17. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007; 30:263-9.
18. Anonymous. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999; 354: 617-21.
19. Ceriello A, Davidson J, Hanefeld M, et al. International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 2006; 16: 453-6.
20. Hanefeld M, Temelkova KT. The postprandial state and the risk of atherosclerosis. Diabetic Medicine 1997; 14: S6-11.